Sales & Marketing The scattered seeds of the beginnings of change - a pharmaph... Speaking with Rob Verheul, CEO of Graphite Digital, at Anthropy 2022 at the Eden Project, pharmaphorum web editor Nicole Raleigh enjoyed a minute discussing the event and
News BI, Click Therapeutics expand collaboration to PDT for schiz... Boehringer Ingelheim (BI) and Click Therapeutics have announced they are expanding their
News Regeneron, CytomX announce bispecific therapeutics for cance... Regeneron Pharmaceuticals, Inc. and CytomX Therapeutics, Inc.
Market Access Philips on designing innovation and cultivating partnerships... This article follows part one of our
Sales & Marketing Preparing for a post-pandemic world Janssen’s Mark Hicken, VP of strategy, EMEA, looks at what COVID-19 has taught us and how we can become stronger as we emerge from the pandemic.
News NICE backs AZ/Ionis' Wainzua for ATTR polyneuropathy AstraZeneca and Ionis' Wainzua has been recommended for NHS use in the treatment of patients with ATTR polyneuropathy
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends
